Clinical Trial Update: Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

This is a status update on a safety and proof-of-concept study of AMT-130 in adults with early manifest Huntington's disease, with the trial currently reported …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• AMT-130

Snippet

Sponsor: UniQure Biopharma B.V. | Conditions: Huntington's Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING